| Filed On | Filing |
|---|---|
| 12 Aug 2026 |
Form 4: Beckerle Mary C, Director
Sold 9,812 shares ($527K) |
| 03 Jun 2026 |
Form 4: Wyszomierski Jack L, Director
Sold 3,925 shares ($198K) |
| 03 Jun 2026 |
Form 4: Eckhardt Sue Gail, Director
Sold 9,812 shares ($492K) |
| 29 May 2026 |
Form 4: Eckhardt Sue Gail, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Smith Julie, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Freire Maria C, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Beckerle Mary C, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Oliver Bob, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Wyszomierski Jack L, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Poste George, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Papadopoulos Stelios, Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Heyman Tomas J., Director
Received 8,367 shares as a grant or award |
| 29 May 2026 |
Form 4: Johnson David Edward, Director and 1 other
Granted 19,133 Option (right to buy) |
| 28 May 2026 |
Form 4: Aftab Dana, EVP, Research and Development
Sold 43,451 shares ($2.19M) |
| 22 May 2026 |
Form 4: Haley Patrick J., EVP, Commercial
Sold 32,110 shares ($1.6M) |
| 19 May 2026 |
Form 4: Morrissey Michael, Director
Gave up 128,497 shares to cover exercise price or tax ($6.57M) · Gave 124,047 shares as a gift · Acquired 124,047 shares (Gift) |
| 19 May 2026 |
Form 4: Senner Christopher J., EVP and CFO
Gave up 40,892 shares to cover exercise price or tax ($2.09M) · Sold 34,901 shares ($1.75M) |
| 19 May 2026 |
Form 4: Haley Patrick J., EVP, Commercial
Gave up 33,265 shares to cover exercise price or tax ($1.7M) |
| 19 May 2026 |
Form 4: Hefti Brenda, SVP and General Counsel
Gave up 6,411 shares to cover exercise price or tax ($328K) · Sold 6,625 shares ($333K) |
| 19 May 2026 |
Form 4: Aftab Dana, EVP, Research and Development
Gave up 30,578 shares to cover exercise price or tax ($1.56M) |
Loading...